Evidence map›Paper›PMID 41756619›Full record

ArticlePrecision chemistry2026

Iridium-Catalyzed Regio- and Enantioselective Hydrogenation of 5‑Alkylidene Cyclopentenones.

Haipeng Wei, Jinbao Ren, Qianjia Yuan, Wei-Ping Deng, Wanbin Zhang

Abstract read
In one paragraph

Article in Precision chemistry, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Haipeng WeiShanghai Key Laboratory for Molecular Engineering of Chiral Drugs, State Key Laboratory of Synergistic Chem-Bio Synthesis, Frontiers Science Center for Transformative Molecules, School of Chemistry and Chemical Engineering, Shanghai Jiao Tong University, 800 Dongchuan Road, Shanghai 200240, China.
Jinbao RenShanghai Key Laboratory for Molecular Engineering of Chiral Drugs, State Key Laboratory of Synergistic Chem-Bio Synthesis, Frontiers Science Center for Transformative Molecules, School of Chemistry and Chemical Engineering, Shanghai Jiao Tong University, 800 Dongchuan Road, Shanghai 200240, China.
Qianjia YuanShanghai Key Laboratory for Molecular Engineering of Chiral Drugs, State Key Laboratory of Synergistic Chem-Bio Synthesis, Frontiers Science Center for Transformative Molecules, School of Chemistry and Chemical Engineering, Shanghai Jiao Tong University, 800 Dongchuan Road, Shanghai 200240, China.
Wei-Ping DengKey Laboratory of the Ministry of Education for Advanced Catalysis Materials, Department of Chemistry, Zhejiang Normal University, Jinhua 321004, China.ORCID https://orcid.org/0000-0002-4232-1318
Wanbin ZhangShanghai Key Laboratory for Molecular Engineering of Chiral Drugs, State Key Laboratory of Synergistic Chem-Bio Synthesis, Frontiers Science Center for Transformative Molecules, School of Chemistry and Chemical Engineering, Shanghai Jiao Tong University, 800 Dongchuan Road, Shanghai 200240, China.ORCID https://orcid.org/0000-0002-4788-4195

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The regio- and enantioselective hydrogenation of the CC bond in molecules with two or more CC bonds of the same type is very challenging but highly desirable. Herein, we report a regio- and enantioselective hydrogenation of 5-alkylidene cyclopentenones catalyzed by an Ir/BiphPHOX complex, delivering the corresponding mono- and double-hydrogenated products in excellent results, respectively (5-substituted cyclopentenones: up to 99% yield and 98% ee; 2,4-disubstituted cyclopentanones: up to 99% yield, 16:1 dr, and 99% ee). For the chiral 2,4-disubstituted cyclopentanones, the results of mechanistic studies indicated that both the exo- and endocyclic CC bonds of the substrate can be preferentially reduced with the exocyclic CC bond undergoing hydrogenation more readily. The ester group in the substrate plays an important role in improving the reactivity and controlling the stereoselectivity of the product. The reaction was successfully conducted on a gram-scale, and the hydrogenated product can be readily derivatized.

Indexed as

asymmetric hydrogenationcyclopentanonecyclopentenoneiridiumregioselectivity

Identifiers

PMID41756619
PMCPMC12933482

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.